Assessing bone pain and survival in SWOG Cancer Research Network 1216 TAK700 in hormone sensitive prostate cancer
Sumanta K.Pal shared a post on X about a recent paper by Georges Gebrael et al., commenting:
“Proud of Georges Gebrael, University of Utah Department of Internal Medicine and Neeraj Agarwal, Huntsman Cancer Institute for a terrific paper in JAMA Network Open assessing bone pain and survival in SWOG Cancer Research Network 1216, a trial of TAK700 in hormone sensitive prostate cancer.”
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial published in National Library of Medicine.
Authors:
Additional information
Source: Sumanta K. Pal/X
Sumanta (Monty) Pal, MD, is a medical oncologist and an expert in genitourinary cancers at the City of Hope Comprehensive Cancer Center in Los Angeles. He serves as the co-director of the Kidney Cancer Program and leads the Kidney and Bladder Cancer Disease Team at City of Hope. He specialises in kidney, bladder, and prostate cancers.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023